Cytokinetics reported $244.33M in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Amgen USD 51.61B 250M Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Biogen USD 7.29B 1.7M Sep/2026
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Bristol-Myers Squibb USD 41.85B 244M Sep/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 244.33M 3.87M Sep/2026
Eisai JPY 184.62B 19M Sep/2026
Eli Lilly USD 46.99B 872M Sep/2026
Geron USD 120.44M 308K Sep/2026
Halozyme Therapeutics USD 2.94B 1.01B Sep/2026
Ionis Pharmaceuticals USD 1.77B 140.62M Sep/2026
Ligand Pharmaceuticals USD 1.13B 679.7M Jun/2026
Merck USD 49.69B 1.39B Sep/2026
Novartis USD 38.38B 893M Sep/2026
Pfizer USD 60B 498M Sep/2026
Regeneron Pharmaceuticals USD 1.99B 400K Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026